Mutation testing - PDFSEARCH.IO - Document Search Engine

Mutation testing
Results: 207

#	Item
51	1207: Final Decision Analytical Protocol (DAP) to guide the assessment of BRAF V600 mutation testing in patients with locally advanced or metastatic melanoma for eligibility for dabrafenib treatment Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:12 Vemurafenib Metastasis Protein kinase inhibitor Cancer Raf kinase Skin cancer Ipilimumab Medicine Melanoma BRAF
52	MSAC Application 1380 Germline BRCA mutation testing to determine eligibility for olaparib maintenance therapy in women with platinum-sensitive relapsed ovarian cancer (including fallopian tube or primary peritoneal canc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-15 23:44:33 Primary peritoneal carcinoma Olaparib Ovarian cancer BRCA mutation Fallopian tube cancer PARP1 Serous carcinoma PARP inhibitor Breast cancer Medicine Oncology Gynaecological cancer
53	1216 Consultation Protocol to guide the assessment of testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene February 2014 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-19 23:54:21 Medical genetics Pancreas disorders Pediatrics Channelopathy Cystic fibrosis Sweat test Congenital absence of the vas deferens Point mutation Genetic testing Biology Health Medicine
54	Public Summary Document Application No[removed]KRAS mutation testing for panitumumab Sponsor/Applicant/s: Amgen Australia Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:51:26 Biotechnology Healthcare in Australia Bristol-Myers Squibb Cetuximab KRAS Panitumumab Colorectal cancer Biomarker Pharmaceutical Benefits Scheme Medicine Biology Health
55	Public Summary Document Application No[removed]KRAS mutation testing for panitumumab Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:51:26 Biotechnology Healthcare in Australia Bristol-Myers Squibb Cetuximab KRAS Panitumumab Colorectal cancer Biomarker Pharmaceutical Benefits Scheme Medicine Biology Health
56	DOCX Document Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:33 Melanoma Organochlorides Sulfonamides Vemurafenib BRAF Melbourne Sports and Aquatic Centre Pharmaceutical Benefits Scheme Mutation testing Cancer Medicine Health Healthcare in Australia
57	The fact sheets have been adapted from material originally prepared by MDA USA with their kind permission. We are grateful for providing this valuable and informative material Facts About Genetics and Neuromuscular Disea Add to Reading List Source URL: mdaustralia.org.au Language: English - Date: 2013-09-20 08:26:11 Genetic disorder Mitochondrion Mitochondrial disease Mutation Chromosome Human genome Mitochondrial DNA Non-Mendelian inheritance Genetic testing Biology Genetics Philosophy of biology
58	ECONOMIC EVALUATION OF THE FAMILIAL CANCER GENETIC SERVICES PROGRAM IN WA GENETIC TESTING FOR FAP Breheny, N1., Geelhoed, E.1 and Familial Cancer Committee, WA Genetics Council. 1 Genomics Directorate, Department of Heal Add to Reading List Source URL: www.genomics.health.wa.gov.au Language: English - Date: 2006-02-01 02:06:02 Hereditary nonpolyposis colorectal cancer Colorectal cancer Cancer Penetrance Genetic testing BRCA mutation Medicine Gastrointestinal cancer Familial adenomatous polyposis
59	Application[removed]Germline BRCA mutation testing to determine eligibility for olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer (including fallopian tube or primary peritoneal canc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-12-15 23:44:34 Carcinoma Primary peritoneal carcinoma Olaparib Ovarian cancer BRCA mutation BRCA2 Cancer Intervention Medicine Oncology Gynaecological cancer
60	Public Summary Document Application No. 1172 – BRAF genetic testing in patients with melanoma for access to proposed PBS-funded vemurafenib Sponsor/Applicant/s: Roche Diagnostic Australia Pty Limited and Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:33 Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Pharmaceutical Benefits Scheme Melbourne Sports and Aquatic Centre Mutation testing Ipilimumab Medicine Health Melanoma

UPDATE